undefined

Martin Fitchett

Chief executive at Medicines for Malaria Venture, interviewed about a new antimalarial drug (GANLUM) and its trial results and prospects for deployment.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app